DNA Sequencing and PCR Markets
The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the generally-accepted DNA-oriented analytical activities that are currently used
...
Publication Date: JUL 2008
|
 |
Microscopy Markets
This TriMark Publications report deals primarily with the analysis of market segments of microscopes used in clinical and research laboratories. Emphasis is on the U.S. markets; however, the worldwide markets are analyzed and discussed as well.
...
Publication Date: JUL 2008
|
|
Stem Cell Markets
The purpose of this report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are
...
Publication Date: JUL 2008
|
|
Genomics World Markets
Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceuti
...
Publication Date: MAY 2008
|
|
Cancer Therapeutics Markets
Cancer is the second leading cause of death by disease in the United States, exceeded only by heart disease. Traditionally cancer has been treated with surgery, chemotherapy, hormones and radiation therapy, alone or in combination. Emerging tec
...
Publication Date: MAY 2008
|
|
RNA Interference Markets
Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry analysts predict that RNA interferen
...
Publication Date: MAY 2008
|
|
Cancer Cell Therapy Markets
Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell pro
...
Publication Date: MAR 2008
|
|
Molecular Diagnostics Markets
The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecul
...
Publication Date: MAR 2008
|
|
Clinical Immunoanalyzer Markets
Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immu
...
Publication Date: DEC 2007
|
|
Veterinary Health Markets
Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving growth in the companion-animal sector. At the same time, concerns ab
...
Publication Date: AUG 2007
|
|
Personalized Medicine
Personalized medicine and pharmacogenomics are inextricably linked. Pharmacogenomics is the use of genetic variations (such as SNPs, gene expression variability, or other molecular signatures) to understand and correlate with differential respo
...
Publication Date: AUG 2007
|
|
Drug Discovery Tools for High-Content Analysis
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those appl
...
Publication Date: JUL 2007
|
|
Cell Therapy Markets
Cell therapy technologies and methods have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Cell therapy is bound to become a
...
Publication Date: JUL 2007
|
|
Gene Expression Reagents Markets
The area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments t
...
Publication Date: APR 2007
|
|
Avian Influenza: The Threatening Pandemic
The purpose of this TriMark Publications report is to describe the threatening world pandemic caused by avian influenza, also known as bird flu. This report discusses the origins of the disease, the bird-to-human infection risks, the catastroph
...
Publication Date: AUG 2006
|
|
Bioinformatics Markets
The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Public
...
Publication Date: JUN 2006
|
|
Microarray Markets
A microarray is an arrangement of miniaturized test sites or "spots" on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules-usually DNA or protein-which act as probes for a test sample appl
...
Publication Date: MAR 2006
|
|
Diabetes, Metabolic Syndrome and Cardiovascular Disease
This TriMark Publications report describes the specific market segment of the pharmaceutical market for diabetes and two of its related diseases, metabolic syndrome and cardiovascular disease. It begins with a textbook explanation of the biolog
...
Publication Date: OCT 2005
|
|
Mammography World Markets
The women's mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher interest of individual patients and general healthcare consumers
...
Publication Date: JAN 2005
|
|
